2023 Q3 Form 10-Q Financial Statement
#000165495423012662 Filed on October 06, 2023
Income Statement
Concept | 2023 Q3 |
---|---|
Revenue | $0.00 |
YoY Change | |
Cost Of Revenue | $0.00 |
YoY Change | |
Gross Profit | $0.00 |
YoY Change | |
Gross Profit Margin | |
Selling, General & Admin | $19.83K |
YoY Change | -32.02% |
% of Gross Profit | |
Research & Development | $0.00 |
YoY Change | |
% of Gross Profit | |
Depreciation & Amortization | |
YoY Change | |
% of Gross Profit | |
Operating Expenses | $19.83K |
YoY Change | -32.02% |
Operating Profit | -$19.83K |
YoY Change | -32.02% |
Interest Expense | $2.824K |
YoY Change | 180.72% |
% of Operating Profit | |
Other Income/Expense, Net | -$2.824K |
YoY Change | -17.18% |
Pretax Income | -$22.65K |
YoY Change | -30.48% |
Income Tax | |
% Of Pretax Income | |
Net Earnings | -$22.65K |
YoY Change | -30.47% |
Net Earnings / Revenue | |
Basic Earnings Per Share | |
Diluted Earnings Per Share | $0.00 |
COMMON SHARES | |
Basic Shares Outstanding | 21.30M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2023 Q3 |
---|---|
SHORT-TERM ASSETS | |
Cash & Short-Term Investments | $27.41K |
YoY Change | 109.56% |
Cash & Equivalents | $27.41K |
Short-Term Investments | |
Other Short-Term Assets | |
YoY Change | |
Inventory | |
Prepaid Expenses | |
Receivables | |
Other Receivables | |
Total Short-Term Assets | $120.7K |
YoY Change | -11.47% |
LONG-TERM ASSETS | |
Property, Plant & Equipment | |
YoY Change | |
Goodwill | |
YoY Change | |
Intangibles | |
YoY Change | |
Long-Term Investments | |
YoY Change | |
Other Assets | |
YoY Change | |
Total Long-Term Assets | $0.00 |
YoY Change | |
TOTAL ASSETS | |
Total Short-Term Assets | $120.7K |
Total Long-Term Assets | $0.00 |
Total Assets | $120.7K |
YoY Change | -11.47% |
SHORT-TERM LIABILITIES | |
YoY Change | |
Accounts Payable | $91.93K |
YoY Change | 20.5% |
Accrued Expenses | $8.448K |
YoY Change | -28.16% |
Deferred Revenue | |
YoY Change | |
Short-Term Debt | $111.1K |
YoY Change | 117.12% |
Long-Term Debt Due | |
YoY Change | |
Total Short-Term Liabilities | $211.5K |
YoY Change | 51.9% |
LONG-TERM LIABILITIES | |
Long-Term Debt | $0.00 |
YoY Change | |
Other Long-Term Liabilities | |
YoY Change | |
Total Long-Term Liabilities | $0.00 |
YoY Change | |
TOTAL LIABILITIES | |
Total Short-Term Liabilities | $211.5K |
Total Long-Term Liabilities | $0.00 |
Total Liabilities | $211.5K |
YoY Change | 51.9% |
SHAREHOLDERS EQUITY | |
Retained Earnings | -$3.520M |
YoY Change | 3.99% |
Common Stock | $21.30K |
YoY Change | 0.0% |
Preferred Stock | |
YoY Change | |
Treasury Stock (at cost) | |
YoY Change | |
Treasury Stock Shares | |
Shareholders Equity | -$90.82K |
YoY Change | |
Total Liabilities & Shareholders Equity | $120.7K |
YoY Change | -11.47% |
Cashflow Statement
Concept | 2023 Q3 |
---|---|
OPERATING ACTIVITIES | |
Net Income | -$22.65K |
YoY Change | -30.47% |
Depreciation, Depletion And Amortization | |
YoY Change | |
Cash From Operating Activities | -$110.00 |
YoY Change | -102.4% |
INVESTING ACTIVITIES | |
Capital Expenditures | |
YoY Change | |
Acquisitions | |
YoY Change | |
Other Investing Activities | $5.450K |
YoY Change | -33.29% |
Cash From Investing Activities | $5.450K |
YoY Change | -33.29% |
FINANCING ACTIVITIES | |
Cash Dividend Paid | |
YoY Change | |
Common Stock Issuance & Retirement, Net | |
YoY Change | |
Debt Paid & Issued, Net | |
YoY Change | |
Cash From Financing Activities | 0.000 |
YoY Change | -100.0% |
NET CHANGE | |
Cash From Operating Activities | -110.0 |
Cash From Investing Activities | 5.450K |
Cash From Financing Activities | 0.000 |
Net Change In Cash | 5.340K |
YoY Change | -143.59% |
FREE CASH FLOW | |
Cash From Operating Activities | -$110.00 |
Capital Expenditures | |
Free Cash Flow | |
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
11440 | usd |
CY2023Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2023Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
21303000 | shares |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> | ||
CY2023Q3 | us-gaap |
Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
|
93249 | usd |
CY2023Q1 | us-gaap |
Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
|
106868 | usd |
hbr |
Seniorsecuredcreditline
SENIORSECUREDCREDITLINE
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 4. SENIOR SECURED CREDIT LINE</strong> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Senior Secured Convertible Credit Line</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 1, 2022, the Company entered a secured convertible note up to $100,000. The secured convertible note matures on July 1, 2023 and bears interest at 8% per annum. The convertible note is secured by 11,000,000 shares of the Company’s common stock held by the Company’s CEO. In the event of an event of default on the note, at the option of the holder, the note can be converted into shares of the Company’s common stock at the conversion price of $0.01 per share. On July 12, 2023, the Company amended the secured convertible note of $100,000 issued on July 1, 2022. The amended secured convertible note was increased to $150,000 and is due on January 1, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of August 31, 2023 and February 28, 2023, the Company has drawn $104,103 and $78,271 on the convertible note, respectively.</p> | ||
CY2022Q3 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
100000 | usd |
CY2022Q3 | us-gaap |
Debt Instrument Description
DebtInstrumentDescription
|
The convertible note is secured by 11,000,000 shares of the Company’s common stock held by the Company’s CEO. In the event of an event of default on the note, at the option of the holder, the note can be converted into shares of the Company’s common stock at the conversion price of $0.01 per share | |
CY2023Q3 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
104103 | usd |
CY2023Q1 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
78271 | usd |
us-gaap |
Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
|
21819 | shares | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1580000 | shares |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.57 | |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1580000 | shares |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.57 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
1260466 | shares | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y9M14D | ||
CY2023Q3 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | usd |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001796949 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--02-28 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | ||
CY2022Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2022Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
21303000 | shares |
CY2023Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
21303000 | shares |
CY2022Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
21303000 | shares |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
0 | ||
CY2023Q1 | us-gaap |
Advances To Affiliate
AdvancesToAffiliate
|
7000 | usd |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-08-31 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
000-56214 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
Healthcare Business Resources Inc. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
84-3639946 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
718 Thompson Lane | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 108-273 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Nashville | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
TN | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
37204 | ||
dei |
City Area Code
CityAreaCode
|
615 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
856-5542 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2023Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
21303000 | shares |
CY2023Q3 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
27411 | usd |
CY2023Q1 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
14192 | usd |
CY2023Q3 | us-gaap |
Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
|
93249 | usd |
CY2023Q1 | us-gaap |
Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
|
106868 | usd |
CY2023Q3 | us-gaap |
Assets Current
AssetsCurrent
|
120660 | usd |
CY2023Q1 | us-gaap |
Assets Current
AssetsCurrent
|
121060 | usd |
CY2023Q3 | us-gaap |
Assets
Assets
|
120660 | usd |
CY2023Q1 | us-gaap |
Assets
Assets
|
121060 | usd |
CY2023Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
91931 | usd |
CY2023Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
91143 | usd |
CY2023Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
8448 | usd |
CY2023Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3368 | usd |
CY2023Q3 | us-gaap |
Advance Rent
AdvanceRent
|
7000 | usd |
CY2023Q1 | us-gaap |
Advance Rent
AdvanceRent
|
7000 | usd |
CY2023Q3 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
104103 | usd |
CY2023Q1 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
78271 | usd |
CY2023Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
211482 | usd |
CY2023Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
179782 | usd |
CY2023Q3 | us-gaap |
Liabilities
Liabilities
|
211482 | usd |
CY2023Q1 | us-gaap |
Liabilities
Liabilities
|
179782 | usd |
CY2023Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
21303 | usd |
CY2023Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
21303 | usd |
CY2023Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
3408074 | usd |
CY2023Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
3386255 | usd |
CY2023Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-3520199 | usd |
CY2023Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-3466280 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-90822 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-58722 | usd |
CY2023Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
120660 | usd |
CY2023Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
121060 | usd |
CY2023Q3 | hbr |
Revenue
Revenue
|
0 | usd |
CY2022Q3 | hbr |
Revenue
Revenue
|
0 | usd |
hbr |
Revenue
Revenue
|
0 | usd | |
hbr |
Revenue
Revenue
|
1884 | usd | |
CY2023Q3 | us-gaap |
Revenues
Revenues
|
0 | usd |
CY2022Q3 | us-gaap |
Revenues
Revenues
|
0 | usd |
us-gaap |
Revenues
Revenues
|
0 | usd | |
us-gaap |
Revenues
Revenues
|
1884 | usd | |
CY2023Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
10452 | usd |
CY2022Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8522 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
23143 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
26580 | usd | |
CY2023Q3 | us-gaap |
Professional Fees
ProfessionalFees
|
9376 | usd |
CY2022Q3 | us-gaap |
Professional Fees
ProfessionalFees
|
20646 | usd |
us-gaap |
Professional Fees
ProfessionalFees
|
25525 | usd | |
us-gaap |
Professional Fees
ProfessionalFees
|
68000 | usd | |
CY2023Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
19828 | usd |
CY2022Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
29168 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
48668 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
94580 | usd | |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-19828 | usd |
CY2022Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-29168 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-48668 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-92696 | usd | |
CY2023Q3 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
0 | usd |
CY2022Q3 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
-2404 | usd |
us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
0 | usd | |
us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
14906 | usd | |
CY2023Q3 | us-gaap |
Interest Expense
InterestExpense
|
2824 | usd |
CY2022Q3 | us-gaap |
Interest Expense
InterestExpense
|
1006 | usd |
us-gaap |
Interest Expense
InterestExpense
|
5251 | usd | |
us-gaap |
Interest Expense
InterestExpense
|
7746 | usd | |
CY2023Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-2824 | usd |
CY2022Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-3410 | usd |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-5251 | usd | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
7160 | usd | |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-22652 | usd |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-32578 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-53919 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-85536 | usd | |
CY2023Q3 | hbr |
Loss Per Share Basic
LossPerShareBasic
|
-0.00 | |
CY2022Q3 | hbr |
Loss Per Share Basic
LossPerShareBasic
|
-0.00 | |
hbr |
Loss Per Share Basic
LossPerShareBasic
|
-0.00 | ||
hbr |
Loss Per Share Basic
LossPerShareBasic
|
-0.00 | ||
CY2023Q3 | hbr |
Loss Per Share Diluted
LossPerShareDiluted
|
-0.00 | |
CY2022Q3 | hbr |
Loss Per Share Diluted
LossPerShareDiluted
|
-0.00 | |
hbr |
Loss Per Share Diluted
LossPerShareDiluted
|
-0.00 | ||
hbr |
Loss Per Share Diluted
LossPerShareDiluted
|
-0.00 | ||
CY2023Q3 | hbr |
Weighted Average Shares Outstanding Basic
WeightedAverageSharesOutstandingBasic
|
20853000 | shares |
CY2022Q3 | hbr |
Weighted Average Shares Outstanding Basic
WeightedAverageSharesOutstandingBasic
|
20853000 | shares |
hbr |
Weighted Average Shares Outstanding Basic
WeightedAverageSharesOutstandingBasic
|
20853000 | shares | |
hbr |
Weighted Average Shares Outstanding Basic
WeightedAverageSharesOutstandingBasic
|
20853000 | shares | |
CY2023Q3 | hbr |
Weighted Average Shares Outstanding Diluted
WeightedAverageSharesOutstandingDiluted
|
20853000 | shares |
CY2022Q3 | hbr |
Weighted Average Shares Outstanding Diluted
WeightedAverageSharesOutstandingDiluted
|
20853000 | shares |
hbr |
Weighted Average Shares Outstanding Diluted
WeightedAverageSharesOutstandingDiluted
|
20853000 | shares | |
hbr |
Weighted Average Shares Outstanding Diluted
WeightedAverageSharesOutstandingDiluted
|
20853000 | shares | |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-58722 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-31267 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-78549 | usd |
CY2023Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
10379 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-22652 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-90822 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-171369 | usd |
CY2022Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
16326 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-52958 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-208001 | usd |
CY2022Q3 | hbr |
Common Shares Issued For Settlement Of Note Payable Related Party Amount
CommonSharesIssuedForSettlementOfNotePayableRelatedPartyAmount
|
225000 | usd |
CY2022Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
12639 | usd |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-32578 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2940 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
-53919 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
-85536 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
21819 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
28965 | usd | |
us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
0 | usd | |
us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
-14906 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
26620 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
50711 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
5080 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-8513 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-400 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-29279 | usd | |
us-gaap |
Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
|
13619 | usd | |
us-gaap |
Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
|
16343 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
13619 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
16343 | usd | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | usd | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
175000 | usd | |
hbr |
Proceeds From Notes Payable Related Party
ProceedsFromNotesPayableRelatedParty
|
0 | usd | |
hbr |
Proceeds From Notes Payable Related Party
ProceedsFromNotesPayableRelatedParty
|
225000 | usd | |
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
0 | usd | |
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
50000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
13219 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-12936 | usd | |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
14192 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
26013 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
27411 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
13077 | usd |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
5135 | usd | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | usd | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | usd | |
us-gaap |
Securities Borrowed Credit Loss Expense Reversal
SecuritiesBorrowedCreditLossExpenseReversal
|
25832 | usd | |
us-gaap |
Securities Borrowed Credit Loss Expense Reversal
SecuritiesBorrowedCreditLossExpenseReversal
|
51174 | usd | |
hbr |
Common Shares Issued For Settlement Of Note Payable Related Party
CommonSharesIssuedForSettlementOfNotePayableRelatedParty
|
0 | usd | |
hbr |
Common Shares Issued For Settlement Of Note Payable Related Party
CommonSharesIssuedForSettlementOfNotePayableRelatedParty
|
225000 | usd | |
CY2023Q2 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
100000 | usd |
hbr |
Increased Decreased In Convetible Note Amount
IncreasedDecreasedInConvetibleNoteAmount
|
150000 | usd | |
CY2023Q3 | us-gaap |
Advances To Affiliate
AdvancesToAffiliate
|
7000 | usd |